Key result
The novel SCN9A mutation in familial erythromelalgia lowers action potential thresholds and induces high-frequency firing in sensory neurons.
Population
A family with erythromelalgia and dorsal root ganglion neurons
Design
Preclinical
Authors
Loading...
May inform SCN9A-targeted pain therapies; leaves open clinical translation from animal models.
This study provides the first evidence linking an inherited pain disorder (erythromelalgia) to a specific ion channel mutation (SCN9A/Nav1.7) that alters the firing of pain-signaling neurons.
Dib‐Hajj et al. (2005) studied this question. The novel SCN9A mutation in familial erythromelalgia lowers action potential thresholds and induces high-frequency firing in sensory neurons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: